Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Therapy for First‐Line Eradication of Helicobacter pylori: A Meta‐Analysis of Randomized Controlled Trials

Tegoprazan‐Containing Versus Proton Pump Inhibitor‐Containing Therapy for First‐Line Eradication of Helicobacter pylori: A Meta‐Analysis of Randomized Controlled Trials

ABSTRACT Introduction Concerns have been raised regarding the decreasing success rates of the standard treatment of Helicobacter pylori (proton pump inhibitor (PPI) and two/three antibiotics) and the long‐term effects carried by PPI. Despite conflicting data, Tegoprazan, a potassium‐competitive acid...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Martin Simadibrata, Elvira Lesmana, Ivan Damara, Mochammad Izzatullah, Pojsakorn Danpanichkul, Hae Won Yoo, Su Jin Hong, Ari Fahrial Syam
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:JGH Open
Subjects:
eradication
Helicobacter pylori
meta‐analysis
proton pump inhibitor
Tegoprazan
Online Access:https://doi.org/10.1002/jgh3.70134
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jgh3.70134

Similar Items